October 2023 ACIP Meeting - Public comment & RSV Vaccines

October 2023 ACIP Meeting - Public comment & RSV Vaccines

Public comment; VOTES; RSV-Adults: Introduction; GSK safety and immunogenicity in persons 50-59 years of age;Epidemiology of RSV in adults;Work group interpretation and ACIP discussion This video can also be viewed at https://www.cdc.gov/vaccines/videos/l...